Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives: The Pan-Canadian Oncology Drug Review

Jeffrey S Hoch, M. Sabharwal

Research output: Contribution to journalArticle

29 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)121-124
Number of pages4
JournalCurrent Oncology
Volume20
Issue number2
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

Canada
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

@article{4ede6771f7de4389b14399e6c356b8d9,
title = "Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives: The Pan-Canadian Oncology Drug Review",
author = "Hoch, {Jeffrey S} and M. Sabharwal",
year = "2013",
doi = "10.3747/co.20.1315",
language = "English (US)",
volume = "20",
pages = "121--124",
journal = "Current Oncology",
issn = "1198-0052",
publisher = "Multimed Inc.",
number = "2",

}

TY - JOUR

T1 - Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives

T2 - The Pan-Canadian Oncology Drug Review

AU - Hoch, Jeffrey S

AU - Sabharwal, M.

PY - 2013

Y1 - 2013

UR - http://www.scopus.com/inward/record.url?scp=84875874701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875874701&partnerID=8YFLogxK

U2 - 10.3747/co.20.1315

DO - 10.3747/co.20.1315

M3 - Article

C2 - 23559876

AN - SCOPUS:84875874701

VL - 20

SP - 121

EP - 124

JO - Current Oncology

JF - Current Oncology

SN - 1198-0052

IS - 2

ER -